OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
OKYO Pharma Limited announces its participation in key upcoming ophthalmic conferences to engage with optometry and ophthalmology experts, underscoring its commitment to developing treatments for neuropathic corneal pain (NCP) and anterior segment eye diseases. The company plans to start a global Phase 3 pivotal clinical trial for its investigation…